Local Anesthetic for Plateau Fractures

ConditionTibial Plateau Fractures

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Washington

About this trial

Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age >=18 year ,

tibial plateau fracture undergoing Open Reduction and fixation"

allergy to bupivacaine

Prolonged external fixator use

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

Bupivacaine injection
Drug
Injection at end of Open Reduction Internal Fixation
Saline
Other intervention
Injection at end of Open Reduction Internal Fixation

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: BupivacaineActive comparator 1 intervention

Group B: SalinePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Pain in the knee visual analogue scale 11 point scale 0(no pain) -10 (worst pain)

Pain at time of visit

Time frame

From date of hospitalization to end of follow-up at 6 months

Secondary outcomes

Length of stay for hospitalization

Time frame

From date of hospitalization up to one month post surgery

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Washington

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: